In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

References

• Kirilov B, Zhelyazkova M, Petkova-Gueorguieva E, et al. Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria. Biotechnol Biotechnol Equip. 2020;34(1):1158–1165.
   Web of Science ®Google Scholar
• Corroon J, Phillips JA. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018;3(1):152–161.
   PubMedGoogle Scholar
• McAllister SD, Murase R, Christian RT, et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat. 2011;129(1):37–47.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Kuzontkoski PM, Groopman JE, et al. Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol Cancer Ther. 2011;10(7):1161–1172.
   PubMed Web of Science ®Google Scholar
• Elbaz M, Nasser MW, Ravi J, et al. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer. Mol Oncol. 2015;9(4):906–919.
   PubMed Web of Science ®Google Scholar
• Massi P, Vaccani A, Bianchessi S, et al. The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci. 2006;63(17):2057–2066.
   PubMed Web of Science ®Google Scholar
• Russo EB. Cannabis therapeutics and the future of neurology. Front Integr Neurosci. 2018;12:51–51.https://doi.org/10.3389/fnint.2018.00051
   PubMed Web of Science ®Google Scholar
• Ramer R, Bublitz K, Freimuth N, et al. Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. Faseb J. 2012;26(4):1535–1548.
   PubMed Web of Science ®Google Scholar
• Ramer R, Heinemann K, Merkord J, et al. COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013;12(1):69–82.
   PubMed Web of Science ®Google Scholar
• Morelli MB, Offidani M, Alesiani F, et al. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. Int J Cancer. 2014;134(11):2534–2546.
   PubMed Web of Science ®Google Scholar
• Pyszniak M, Tabarkiewicz J, Łuszczki JJ. Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance. Oncol Targets Ther. 2016;9(9):4323–4336.
   PubMedGoogle Scholar
• Laun AS, Song ZH. GPR3 and GPR6, novel molecular targets for cannabidiol. Biochem Biophys Res Commun. 2017;490(1):17–21.
   PubMed Web of Science ®Google Scholar
• Iannotti FA, Hill CL, Leo A, et al. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci. 2014;5(11):1131–1141.
   PubMed Web of Science ®Google Scholar
• Neumann-Raizel H, Shilo A, Lev S, et al. 2-APB and CBD-mediated targeting of charged cytotoxic compounds into tumor cells suggests the involvement of TRPV2 channels. Front Pharmacol. 2019;10:1198.
   PubMed Web of Science ®Google Scholar
• Straiker A, Dvorakova M, Zimmowitch A, et al. Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons. Mol Pharmacol. 2018;94(1):743–748. https://doi.org/10.1124/mol.118.111864
   PubMed Web of Science ®Google Scholar
• Bih CI, Chen T, Bazelot M, et al. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015;12(4):699–730.
   PubMed Web of Science ®Google Scholar
• Nathan I, Vogel Z, Uppalapati LN, et al. 2018. Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer. U.S. Patent and Trademark Office. Available from: https://patentscope.wipo.int/search/en/detail.jsf?docId=US232561348
   Google Scholar
• Aviello G, Romano B, Borrelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl). 2012;90(8):925–934.
   PubMed Web of Science ®Google Scholar
• Torres S, Lorente M, Rodriguez-Fornes F, et al. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther. 2011;10(1):90–103.
   PubMed Web of Science ®Google Scholar
• Strong T, Rauvolfova J, Jackson E, et al. Synergistic effect of cannabidiol with conventional chemotherapy treatment. Blood. 2018;132:1(Supplement 1):5382–5382.
   Google Scholar
• Deng L, Ng L, Ozawa T, et al. Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture. J Pharmacol Exp Ther. 2017;360(1):215–224.
   PubMed Web of Science ®Google Scholar
• Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440–446.
   PubMed Web of Science ®Google Scholar
• Chou TC, Talalay P. Quantitive analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.
   PubMedGoogle Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63.
   PubMed Web of Science ®Google Scholar
• Konstantinov SM, Eibl H, Berger MR. BCR-ABL influences the antileukaemic efficacy of alkylphosphocholines. Br J Haematol. 1999;107(2):365–374.
   PubMed Web of Science ®Google Scholar
• Sadowska-Bartosz I, Galiniak S, Bartosz G. Modification of the deoxyribose test to detect strong iron binding. Acta Biochim Pol. 2017;64(1):195–198.
   PubMed Web of Science ®Google Scholar
• Hadjimitova V, Traykov T, Mileva M, et al. Effect of some psychotropic drugs on luminol-dependent chemiluminescence induced by O2-, *OH, HOCl. Z Naturforsch C J Biosci. 2002;57(11–12):1066–1071.
   PubMedGoogle Scholar
• Radi R, Rubbo H, Thomson L, et al. Luminol chemiluminescence using xanthine and hypoxanthine as xanthine oxidase substrates. Free Radic Biol Med. 1990;8(2):121–126.
   PubMed Web of Science ®Google Scholar
• Scott KA, Shah S, Dalgleish AG, et al. Enhancing the activity of cannabidiol and other cannabinoids in vitro through modifications to drug combinations and treatment schedules. Anticancer Res. 2013;33(10):4373–4380.
   PubMed Web of Science ®Google Scholar
• Scott KA, Dalgleish AG, Liu WM. Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration. Int J Oncol. 2017;51(1):369–377.
   PubMed Web of Science ®Google Scholar
• Likar R, Nahler G. The use of cannabis in supportive care and treatment of brain tumor. Neurooncol Pract. 2017;4(3):151–160.
   PubMed Web of Science ®Google Scholar
• Holland ML, Panetta JA, Hoskins JM, et al. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem Pharmacol. 2006;71(8):1146–1154.
   PubMed Web of Science ®Google Scholar
• Molnár J, Szabó D, Pusztai R, et al. Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates. Anticancer Res. 2000;20(2A):861–867.
   PubMed Web of Science ®Google Scholar
• BC Cancer Agency. Epirubicin monongraph. Vancouver (BC): BC Cancer Agency; 2017.
   Google Scholar
• Solinas M, Massi P, Cinquina V, et al. Cannabidiol, a non-psychoactive cannabinoid compound, inhibits proliferation and invasion in U87-MG and T98G glioma cells through a multitarget effect. PLoS One. 2013;8(10):e76918.
   PubMed Web of Science ®Google Scholar
• De Petrocellis L, Ligresti A, Schiano Moriello A, et al. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. Br J Pharmacol. 2013;168(1):79–102.
   PubMed Web of Science ®Google Scholar
• Grankvist K, Henriksson R. Doxorubicin and epirubicin iron-induced generation of free radicals in vitro. A comparative study. Biosci Rep. 1987;7(8):653–658.
   PubMed Web of Science ®Google Scholar
• Genaro-Mattos TC, Dalvi LT, Oliveira RG, et al. Reevaluation of the 2-deoxyribose assay for determination of free radical formation. Biochim Biophys Acta. 2009;1790(12):1636–1642.
   PubMed Web of Science ®Google Scholar
• Malisza KL, Hasinoff BB. Production of hydroxyl radical by iron(III)-anthraquinone complexes through self-reduction and through reductive activation by the xanthine oxidase/hypoxanthine system. Arch Biochem Biophys. 1995;321(1):51–60.
   PubMed Web of Science ®Google Scholar
• Pritsos CA. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact. 2000;129(1–2):195–208.
   PubMed Web of Science ®Google Scholar
• Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants. 2019;9(1):21.
   Web of Science ®Google Scholar
• Gómez CT, Lairion F, Repetto M, et al. Cannabidiol (CBD) alters the functionality of neutrophils (PMN). Implications in the refractory epilepsy treatment. Pharmaceuticals. 2021;14(3):220.
   Web of Science ®Google Scholar